Stay updated on Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial
Sign up to get notified when there's something new on the Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial page.

Latest updates to the Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page displays Revision: v3.5.4 instead of Revision: v3.5.3. This indicates a minor release to the site’s revision labeling rather than substantive content changes.SummaryDifference0.0%

- Check20 days agoChange DetectedNo additions or deletions are documented for this page. There is nothing to compare against the current content.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page’s footer/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a minor ClinicalTrials.gov release. No study details (e.g., design, outcomes, eligibility, or dates) appear to have changed.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision: v3.5.2 has been introduced. The previous revision v3.5.0 has been removed.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision: v3.5.0 was added. Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check78 days agoChange DetectedResults posted for the study (NCT05446740), including dose-level data, study design details, and outcome measures; the page now displays a Results Posted section with related documents.SummaryDifference6%

Stay in the know with updates to Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial page.